Related Experiment Video
Updated: Oct 27, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Methylation and expression levels of microRNA-23b/-24-1/-27b, microRNA-30c-1/-30e, microRNA-301a and let-7g are
I Gilyazova1,2, E Ivanova3, G Gilyazova2
1Institute of Biochemistry and Genetics - Subdivision, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russian Federation, 450054.
Background:
Renal cell carcinoma is the most common form of kidney cancer in adults. DNA methylation of regulatory sequences at the genomic level and interaction between microRNAs and the messenger RNAs of target genes at the posttranscriptional level contribute to the dynamic regulation of gene activity. Aberrations in these mechanisms can result in impaired functioning of cell signaling pathways, such as that observed in malignant tumors. We hypothesized that microRNA genes methylation may be associated with renal cancer in patients.
Methods And Results:
We examined methylation levels of 22 microRNA genes in tumor and normal kidney tissue of 30 patients with TNM Stage III clear cell renal cell carcinoma using a pathway-specific real-time polymerase chain reaction array (EpiTect Methyl II PCR Arrays, Qiagen). MicroRNA expression analysis by quantitative polymerase chain reaction was also performed. Significant differences in methylation levels were found in two genes and in two clusters of microRNA genes. MicroRNA-23b/-24-1/-27b, microRNA -30c-1/-30e and let-7 g was hypermetylated in clear cell renal cell carcinoma tissue, microRNA -301a was hypomethylated in tumor compared with the adjacent normal tissues. Expression of microRNA-301a, microRNA-23b in the clear cell renal cell carcinoma tissues was significantly overexpressed when compared with the adjacent normal tissues and let-7 g was significantly downregulated in tumor.
Conclusions:
Our results may indicate the contribution of microRNA-301a, microRNA-23b and let-7 g in the pathogenesis of renal cancer, but further studies are needed to determine the functional significance of the detected changes.
Insights
MicroRNA gene methylation changes, specifically involving microRNA-301a, microRNA-23b, and let-7g, are associated with clear cell renal cell carcinoma development. Further research is needed to confirm their role in kidney cancer pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Renal cell carcinoma (RCC) is the predominant kidney cancer in adults.
- DNA methylation and microRNA regulation are key in controlling gene activity.
- Dysregulation of these mechanisms can lead to cellular signaling pathway impairment, as seen in cancers.
Purpose of the Study:
- To investigate the potential association between microRNA gene methylation and renal cancer.
- To explore the methylation status and expression levels of specific microRNAs in clear cell renal cell carcinoma (ccRCC).
Main Methods:
- Analyzed methylation levels of 22 microRNA genes in tumor and normal kidney tissues from 30 ccRCC patients (TNM Stage III).
- Utilized a pathway-specific real-time polymerase chain reaction array for methylation analysis.
- Performed quantitative polymerase chain reaction for microRNA expression profiling.
Main Results:
- Identified significant methylation differences in specific microRNA genes and clusters.
- Observed hypermethylation of microRNA-23b/-24-1/-27b, microRNA-30c-1/-30e, and let-7g in ccRCC tissues.
- Found hypomethylation of microRNA-301a in tumor tissues compared to normal tissues.
- Detected significant overexpression of microRNA-301a and microRNA-23b, and downregulation of let-7g in ccRCC.
Conclusions:
- Results suggest a potential role for microRNA-301a, microRNA-23b, and let-7g in the pathogenesis of renal cancer.
- Further studies are required to elucidate the functional significance of these observed epigenetic and expression changes in ccRCC.
Related Concept Videos
MicroRNAs
MicroRNAs

